Woodrow G, Oldroyd B, Turney J H, Davies P S, Day J M, Smith M A
Renal Unit, Leeds General Infirmary, UK.
Eur J Clin Nutr. 1996 Oct;50(10):676-81.
Abnormalities of body hydration are common in patients with advanced chronic renal failure (CRF) and may be associated with important adverse clinical effects, even in the absence of clinical features of fluid retention or depletion. Bioelectrical impedance analysis (BIA) is a simple, non-invasive method of measuring body water content and thus could be of use in the management and study of patients with CRF. This study was performed to assess the ability of BIA to measure total body water (TBW) in patients with CRF.
TBW was measured by two different impedance systems, with comparison of the results with TBW determined by deuterium oxide dilution (D2O).
Renal Unit, Leeds General Infirmary and Centre for Bone and Body Composition Research, University of Leeds, UK.
The range of the 95% limits of method agreement between BIA and D2O expressed as a percentage of the mean for the group was +/- 13.4% for the RJL 101A system and +/- 15.6% for the Holtain system in controls. For the whole CRF group the limits were moderately greater than controls at +/- 17.3% (RJL) and +/- 21.9% (Holtain). Analysis of subgroups of the CRF patients showed the smallest limits in those receiving peritoneal dialysis (+/- 15.5% RJL and 18.2% Holtain). Limits were greater for patients on haemodialysis (+/- 16.0% RJL and +/- 23.8% Holtain) and undialysed patients (+/- 20.1% and +/- 23.0%).
BIA is less accurate for the measurement of TBW in patients with CRF than in healthy subjects, though in some groups of patients the effect of CRF on the validity of this technique may be only mild. Abnormalities of reactance suggest that abnormal variability in the distribution of fluid between intra- and extracellular compartments is the major cause of reduced accuracy of TBW calculated by BIA in CRF patients.
在晚期慢性肾衰竭(CRF)患者中,身体水合异常很常见,并且可能与重要的不良临床后果相关,即使在没有液体潴留或缺失的临床特征时也是如此。生物电阻抗分析(BIA)是一种测量身体含水量的简单、非侵入性方法,因此可用于CRF患者的管理和研究。本研究旨在评估BIA测量CRF患者全身水(TBW)的能力。
通过两种不同的阻抗系统测量TBW,并将结果与用氧化氘稀释法(D2O)测定的TBW进行比较。
英国利兹总医院肾脏科以及利兹大学骨与身体成分研究中心。
在对照组中,BIA与D2O之间方法一致性的95%界限范围,以该组均值的百分比表示,RJL 101A系统为±13.4%,Holtain系统为±15.6%。对于整个CRF组,界限略大于对照组,RJL系统为±17.3%,Holtain系统为±21.9%。对CRF患者亚组的分析显示,接受腹膜透析的患者界限最小(RJL系统为±15.5%,Holtain系统为18.2%)。血液透析患者(RJL系统为±16.0%,Holtain系统为±23.8%)和未透析患者(±20.1%和±23.0%)的界限更大。
与健康受试者相比,BIA测量CRF患者TBW的准确性较低,不过在某些患者组中,CRF对该技术有效性的影响可能较小。电抗异常表明,细胞内和细胞外液腔之间液体分布的异常变化是CRF患者中BIA计算TBW准确性降低的主要原因。